BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18581405)

  • 21. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
    Kim JH; Kim JK; Park BW; Kim N; Cho KS
    J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
    Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
    J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
    Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues.
    Liu X; Zhou L; Peng W; Wang H; Zhang Y
    J Magn Reson Imaging; 2015 Oct; 42(4):1078-85. PubMed ID: 25727776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging.
    Liu X; Zhou L; Peng W; Qian M
    Acta Radiol; 2011 Jun; 52(5):575-80. PubMed ID: 21498291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
    Shi H; Ding HY
    Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.
    Hansford BG; Karademir I; Peng Y; Jiang Y; Karczmar G; Thomas S; Yousuf A; Antic T; Eggener S; Oto A
    Acad Radiol; 2014 May; 21(5):569-77. PubMed ID: 24703469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
    Iwazawa J; Mitani T; Sassa S; Ohue S
    Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results.
    Quentin M; Pentang G; Schimmöller L; Kott O; Müller-Lutz A; Blondin D; Arsov C; Hiester A; Rabenalt R; Wittsack HJ
    Magn Reson Imaging; 2014 Sep; 32(7):880-5. PubMed ID: 24848289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced ultrasonography evaluation of radiofrequency ablation of the prostate: a canine model.
    Hu B; Hu B; Chen L; Li J; Huang J
    J Endourol; 2010 Jan; 24(1):89-93. PubMed ID: 20059384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance-guided high-intensity ultrasound ablation of the prostate.
    Pauly KB; Diederich CJ; Rieke V; Bouley D; Chen J; Nau WH; Ross AB; Kinsey AM; Sommer G
    Top Magn Reson Imaging; 2006 Jun; 17(3):195-207. PubMed ID: 17414077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.